Tomczak, P. 2025. Cabozantinib in monotherapy and combination therapy for first-line renal cell carcinoma: Patient profiles. OncoReview. 15, 1(57) (Jun. 2025), 12-17. DOI:https://doi.org/10.24292/01.OR.151220925.